The Therapeutic and Diagnostic Potential of Amyloid β Oligomers Selective Antibodies to Treat Alzheimer’s Disease

Improvements have been made in the diagnosis of Alzheimer’s disease (AD), manifesting mostly in the development of in vivo imaging methods that allow for the detection of pathological changes in AD by magnetic resonance imaging (MRI) and positron emission tomography (PET) scans. Many of these imagin...

Descripción completa

Detalles Bibliográficos
Autores principales: Viola, Kirsten L., Bicca, Maira A., Bebenek, Adrian M., Kranz, Daniel L., Nandwana, Vikas, Waters, Emily A., Haney, Chad R., Lee, Maxwell, Gupta, Abhay, Brahmbhatt, Zachary, Huang, Weijian, Chang, Ting-Tung, Peck, Anderson, Valdez, Clarissa, Dravid, Vinayak P., Klein, William L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761808/
https://www.ncbi.nlm.nih.gov/pubmed/35046767
http://dx.doi.org/10.3389/fnins.2021.768646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761808/
https://www.ncbi.nlm.nih.gov/pubmed/35046767
http://dx.doi.org/10.3389/fnins.2021.768646

Ejemplares similares